Li D. .2020 .Diagnostic accuracy of ELISA in clinical laboratory testing. , 11 : 1786.
Tuaillon E. . .Comparison of serological assays for disease detection. ” Clinical Microbiology Reviews, 35(2022) : e00085-21.
.2023 .Laboratory testing strategies and diagnostic accuracy of immunoassays. ” WHO Technical Report Series, : .
Otto M. .2020 .Staphylococcus haemolyticus: A major player in the emergence of multidrug-resistant staphylococci. ” Future Microbiology, 15 : 637-650.
Becker K. . .Coagulase-negative staphylococci. ” Clinical Microbiology Reviews, 27(2014) : 870-926.
Cui L. .2021 .Quorum sensing systems and biofilm formation in coagulase-negative staphylococci. , 12 : 659196.
Ponnanikajamideen M. .2020 .Anti-biofilm activity of metal oxide nanoparticles against pathogenic bacteria. ” Journal of Photochemistry and Photobiology B, 210 : 111989.
Elkodous Abd,M. Abd . .Green synthesis of nanoparticles: Applications and limitations. Nanotechnology Reviews, 9(2020) : 182-213.
Ahmed S. .2021 .Green synthesis of metal oxide nanoparticles using plant extracts and their antimicrobial applications. ” Biotechnology Reports, 30 : e00664.
Al-Khafaji Z.M.,Al-Saadi M.A.K. . .Biofilm formation and antimicrobial resistance among coagulase-negative staphylococci isolated from urinary tract infections. Iranian Journal of Microbiology, 13(2021) : 310-318.
Khashan K.S. . .Antibacterial activity of magnesium oxide nanoparticles against multidrug-resistant bacteria. ” Materials Research Express, 7(2020) : 015084.
Mahmoudi S. .2021 .The agr quorum-sensing system and its role in staphylococcal virulence regulation. ” Microbial Pathogenesis, 158 : 105084.
Al-Zubaidi A.F . .Biofilm formation and virulence gene expression in multidrug-resistant staphylococci isolated from clinical samples. ” Microbes and Infectious Diseases, 4(2023) : 345-354.
.2017 .Global priority list of antibioticresistant bacteria. , : .
.2016 .Global health sector strategy on viral hepatitis 2016-2021. , : .
Roudot-Thoraval F. .2021 .Epidemiology of hepatitis C virus infection. ” Clinical Research in Hepatology and Gastroenterology, 45 : 101596.
Lewis K.C. .2023 .” Clinical Infectious Diseases. , 77 : 1413-1415.
Messina V. . .Hepatitis C virus micro-elimination in the hospital setting: The results of the HCV Caserta hospital project. ” Journal of Infection and Public Health, 15(2022) : 562-565.
Clinical Chemistry . .. , 66(2020) : 282-287.
.2023 .” Clinical Infectious Diseases. , 77 : 1413-1415.
Zou B. .1999 .Prevalence of viremic hepatitis C virus infection by age, race/ethnicity, and birthplace and disease awareness among viremic persons in the United States,. ” Journal of Infectious Diseases, 221(2020) : 408-418.
Singh P. .2022 .Biological synthesis of nanoparticles and their role in biofilm inhibition. ” Colloids and Surfaces B: Biointerfaces, 215 : 112522.